These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30259297)

  • 21. Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
    Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
    Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.
    Noel EE; Yeste-Velasco M; Mao X; Perry J; Kudahetti SC; Li NF; Sharp S; Chaplin T; Xue L; McIntyre A; Shan L; Powles T; Oliver RT; Young BD; Shipley J; Berney DM; Joel SP; Lu YJ
    Am J Pathol; 2010 Jun; 176(6):2607-15. PubMed ID: 20395447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
    Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of testicular germ cell tumors.
    Singla N; Lafin JT; Ghandour RA; Kaffenberger S; Amatruda JF; Bagrodia A
    Curr Opin Urol; 2019 Jul; 29(4):344-349. PubMed ID: 31045925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations.
    Oing C; Skowron MA; Bokemeyer C; Nettersheim D
    Andrology; 2019 Jul; 7(4):487-497. PubMed ID: 30924611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
    Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
    Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
    Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
    Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
    Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic evolution and chemoresistance in germ-cell tumours.
    Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
    Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
    Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
    Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors.
    Chieffi P
    Curr Med Chem; 2011; 18(33):5033-40. PubMed ID: 22050751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
    Lengert AVH; Pereira LDNB; Cabral ERM; Gomes INF; Jesus LM; Gonçalves MFS; Rocha AOD; Tassinari TA; Silva LSD; Laus AC; Vidal DO; Pinto MT; Reis RM; Lopes LF
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):245. PubMed ID: 36042160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.
    Timmerman DM; Eleveld TF; Sriram S; Dorssers LCJ; Gillis AJM; Schmidtova S; Kalavska K; van de Werken HJG; Oing C; Honecker F; Mego M; Looijenga LHJ
    J Clin Oncol; 2022 Sep; 40(26):3077-3087. PubMed ID: 35442716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCPH expression is an early event in the development of testicular germ cell tumors.
    Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
    Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
    Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
    Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
    Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
    BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
    Chieffi P
    J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the role of endocrine disrupting chemicals in testicular germ cell cancer: Insights into molecular mechanisms.
    Pang WK; Kuznetsova E; Holota H; De Haze A; Beaudoin C; Volle DH
    Mol Aspects Med; 2024 Oct; 99():101307. PubMed ID: 39213722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
    Noel EE; Perry J; Chaplin T; Mao X; Cazier JB; Joel SP; Oliver RT; Young BD; Lu YJ
    Genes Chromosomes Cancer; 2008 Jul; 47(7):604-13. PubMed ID: 18384131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.